Study of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid Tumors

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid Tumors	Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma	Active, not recruiting	Phase 1 / Phase 2	2026-07-10		NCT05101096

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Gilead Sciences	180

36 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Aichi Cancer Center Hospital	Aichi	Japan	6
Akita University Hospital	Akita	Japan	7
Chiba Cancer	Chūōku	Japan	1
Chiba Cancer Center	Chiba	Japan	27
Hirosaki University Hospital	Aomori	Japan	2
Hiroshima University Hospital	Minamiku	Japan	1
Hyogo Cancer Center	Hyōgo	Japan	6
Hyogo College of Medicine College Hospital	Nishinomiya-shi	Japan	1
Juntendo University Hospital	Bunkyō City	Japan	21
Kagawa University Hospital	Kagawa	Japan	6
Kanagawa Cancer Center	Asahi-ku	Japan	1
Keio University Hospital	Tokyo	Japan	2
Kindai University Hospital	Osaka	Japan	2
Kindai University Hospital	Osakasayama-shi	Japan	5
Kumamoto University Hospital	Kumamoto	Japan	45
Kyoto University Hospital	Kyoto	Japan	56
Nagoya University Hospital	Chūōku	Japan	1
Nara Medical University Hospital	Nara	Japan	1
National Cancer Center Hospital	Tokyo	Japan	42
National Cancer Center Hospital East	Chiba	Japan	25
National Center For Global Health And Medicine	Shinjuku-Ku	Japan	3
National Hospital Organization Hokkaido Cancer Center	Sapporo	Japan	10
National Hospital Organization Shikoku Cancer Center	Ehime	Japan	4
Okayama University Hospital	Okayama	Japan	75
Osaka International Cancer Institute	Chūōku	Japan	4

Clinical trials